pheochromocytoma - Neuroendocrine Cancer UK

Share Your Neuroendocrine Cancer Diagnosis Journey and Help Shape the Future of Care

by Beth Chesser | Aug 28, 2026

For many people living with neuroendocrine cancer, the journey to diagnosis can be long, complex and filled with uncertainty. Symptoms are often difficult to recognise, may be attributed to other conditions, or can be overlooked before the correct diagnosis is finally...

Sunitinib efficacy in Pheochromocytoma and Paraganglioma

by Leanne Talbot | Sep 24, 2021

#ESMO2021 Rare NETs: Sunitinib efficacy in #Pheochromocytoma and #Paraganglioma – “A strong result for a treatment based on sound mechanistic principle,” says Prof Juan Valle, University of Manchester & Dept of Medical Oncology at The Christie...

Para Pheo Patient Survery

by Leanne Talbot | Apr 26, 2021

Have you been seen at the University of Cambridge in the UK in the past year for pheochromocytoma (pheo) paraganglioma (para)? This center has applied for a Center of Excellence designation from the Pheo Para Alliance and one of the criteria to be evaluated for...

Share Your Neuroendocrine Cancer Diagnosis Journey and Help Shape the Future of Care

Sunitinib efficacy in Pheochromocytoma and Paraganglioma

Para Pheo Patient Survery

About Us

Subscribe

Contact

Helpline: 0800 434 6476

Office: 01926 883 487

Holly House, 74 Upper Holly Walk, Leamington Spa CV32 4JL

Email us